Target intelligence / Profile preview

Transcription factor HES1 (HES1)

Target
HES1
Molecular classification
Transcription factor, Basic helix-loop-helix (bHLH) family, Repressor
01

Overview

Transcription factor HES1 (Hairy and enhancer of split 1) is a basic helix-loop-helix (bHLH) protein that serves as a primary downstream effector of the Notch signaling pathway. It plays a critical role in developmental processes and adult tissue homeostasis by regulating the balance between cell proliferation and differentiation, especially in neural, hematopoietic, and gastrointestinal systems. HES1 functions mainly as a transcriptional repressor, binding to specific DNA sequences such as the N-box and recruiting co-repressors like TLE/Groucho and histone deacetylases (HDACs) to silence genes that would otherwise promote differentiation. In various human malignancies, including T-cell acute lymphoblastic leukemia and pancreatic cancer, HES1 is aberrantly overexpressed, contributing to tumor survival, the maintenance of cancer stem cells, and resistance to chemotherapy. Therapeutic targeting of HES1 is being explored through direct small-molecule inhibitors like JI051 and repurposed drugs such as perhexiline, which antagonizes HES1-associated transcriptional signatures. However, because HES1 is vital for normal stem cell function and tissue regeneration, its pharmacological modulation presents significant safety challenges and therapeutic risks.

Other names
Hairy and enhancer of split 1HES-1HRYhHLbHLHb39Hes family bHLH transcription factor 1
02

Mechanism of action

Transcription repression through DNA binding to N-box and E-box motifs and recruitment of corepressor complexes (TLE/Groucho/HDAC)

03

Biological functions

Notch signalingCell differentiationCell proliferationStem cell maintenanceNeurogenesisApoptosis regulationEmbryonic development
04

Disease associations

CancerT-cell acute lymphoblastic leukemiaPancreatic cancerGlioblastomaBreast cancerOsteopeniaNeurodegenerative disease
05

Safety considerations

Developmental toxicityImpaired tissue regenerationStem cell depletionSystemic Notch pathway toxicity
06

Interacting drugs

Perhexiline

3 more in the full profile.

07

Biomarkers

HES1 mRNA expression levelsHES1 protein levelsHES1-driven gene signature

Beyond the preview

Go deeper on Transcription factor HES1 (HES1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transcription factor HES1 (HES1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call